Medicamen Biotech Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 330.88 million compared to INR 275.3 million a year ago. Revenue was INR 340.5 million compared to INR 276.09 million a year ago. Net income was INR 35.86 million compared to INR 41.51 million a year ago. Basic earnings per share from continuing operations was INR 2.94 compared to INR 3.4 a year ago. Diluted earnings per share from continuing operations was INR 2.94 compared to INR 3.4 a year ago.